Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 10

Canagliflozin improves risk factors of metabolic syndrome in patients with type 2 diabetes mellitus and metabolic syndrome

Total article views   HTML views PDF downloads Totals
11,077 Dovepress* 10,239+ 2,197 12,436
PubMed Central* 838 399 1,237
Totals 11,077 2,596 13,673
*Since 27 January 2017
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar